by Holly Wobma | Apr 26, 2017
For anybody who has invested a great deal of time into a research project, you probably feel a certain sense of expertise on the topic. Sure, it is impossible to know a whole field (every answer raises more questions), and lab work is rife with puzzlement and...
by David Kent | Apr 18, 2017
With the Toronto Blue Jays* off to a terrible start, I was almost dissuaded from reading anything about baseball, until I happened upon the following article: “Stem-cell therapy is poised to disrupt the Tommy John epidemic in baseball.” First, I had to do my standard...
by Stacey Johnson | Apr 14, 2017
If you are a knowledge worker, it may seem as though “innovation” is on everyone’s lips these days. First, Canadians saw Industry Canada renamed Innovation, Science and Economic Development when Prime Minister Trudeau unveiled his first cabinet. Then, Budget 2017,...
by Elizabeth Csaszar | Mar 27, 2017
Research and development (R&D) of a medical therapeutic is a long slog. This isn’t news to anyone working in the field. The average time to bring a new drug product to market is over a decade. Moreover, this is the timeline when everything progresses well –...
by Stacey Johnson | Feb 10, 2017
There is a trend in the regenerative medicine field to include gene therapies when describing the work being performed by academics and industry, as in “cell and gene therapies.” The wider definition better reflects how the industry is evolving and acknowledges the...
Comments